Association between sedative-hypnotic medication use and incidence of cancer in Korean Nation Health Insurance Service data

2019 ◽  
Vol 60 ◽  
pp. 159-164
Author(s):  
Sun Jae Jung ◽  
Joonki Lee ◽  
Jae-Won Choi ◽  
Soohyun Kim ◽  
Aesun Shin ◽  
...  
2017 ◽  
Vol 21 (2) ◽  
pp. 66 ◽  
Author(s):  
Jong-Kil Kim ◽  
Young-Ran Jung ◽  
Kyung-Tae Kim ◽  
Chung-Shik Shin ◽  
Kwang-Bok Lee

PLoS Medicine ◽  
2019 ◽  
Vol 16 (3) ◽  
pp. e1002763 ◽  
Author(s):  
Rishi J. Desai ◽  
Ameet Sarpatwari ◽  
Sara Dejene ◽  
Nazleen F. Khan ◽  
Joyce Lii ◽  
...  

2019 ◽  
Vol 36 (6) ◽  
pp. 785-790
Author(s):  
Katharina Schmalstieg-Bahr ◽  
Christiane A Müller ◽  
Eva Hummers

Abstract Background In Germany, almost 50% of prescriptions for benzodiazepines and drugs as Zolpidem and Zopiclone are as out-of-pocket (OOP) prescriptions—requiring patients to buy the drug at their own expense—although almost 90% of the population has statutory health insurance covering medication costs. Objective To understand why general practitioners (GPs) choose this prescribing method since needed medications are insurance covered, and unnecessary drugs should not be prescribed at all. Methods In this qualitative study, 17 semi-structured interviews with GPs were conducted, audio recorded and transcribed verbatim. Transcripts were analysed with grounded theory to extract a model explaining the described behaviour. Results Knowing the significant medical risks and insecurity about regulations makes GPs wish to avoid hypnotics and sedatives. They achieve this by ‘Creating a barrier’ (central phenomenon) and employing the strategy ‘Using an out-of-pocket prescription’, which not only generates costs for the patient but also reduces the physicians´ legal and financial accountability. The perceived patient type, expected problem duration and diagnosis influence the decision about the prescription form: patients with an alcohol or drug addiction or those with ‘uncomplicated’ insomnia are more likely to receive an OOP prescription. Patients with any psychiatric diagnosis will likely receive a statutory health insurance prescription. Discussion Current regulations do not provide guidance to GPs regarding hypnotics and sedatives. A clear regulatory framework and guidelines could possibly reduce physicians’ defensive attitudes about these drugs and their use of OOP prescriptions. The approach to use OOP prescriptions as a barrier to reduce patients’ medication use lacks evidence regarding effectiveness.


2015 ◽  
Vol 105 (8) ◽  
pp. e64-e69 ◽  
Author(s):  
Ryan N. Hansen ◽  
Denise M. Boudreau ◽  
Beth E. Ebel ◽  
David C. Grossman ◽  
Sean D. Sullivan

2020 ◽  
Vol 20 (4) ◽  
pp. 175-181
Author(s):  
Hyun-Soo Kang ◽  
Min-Taek Lim ◽  
Bo-Yeon Kim ◽  
Kyong-Do Han ◽  
Keun-Mi Lee ◽  
...  

Background: The Korean Health Insurance Review and Assessment Service has conducted diabetes medical adequacy evaluation projects since 2010. This study aimed to evaluate the medical adequacy of type 2 diabetes mellitus patients after the assessment project and help establish the direction of future projects.Methods: Using data from the Health Insurance Review & Assessment Service (2010-2015), chi-square tests and t-tests were used to analyze the enforcement rate according to a combination of items for appropriate management methods. Logistic regression and linearity test were performed to assess the relationships among the evaluation group, appropriate test items, and prescription rate.Results: We found that 33.6-39.8% of patients did not undergo any diabetes-related tests. Only about 7% of hemoglobin A1c (HbA1c) tests were performed, and 36% of cases were tested simultaneously with serum lipid profile tests. As age increased, the number of days taken to prescribe diabetes medications also increased.The prescription rate of diabetes drugs for 292 days or more was 61% in patients who had not been tested for adequacy, and the average prescription rate increased as the number of tests increased.Conclusions: In older adults with a high prevalence of diabetes, it is necessary to establish a test rate for proper management of diabetes, including HbA1c, and related test items to increase the average prescription rate.


2017 ◽  
Vol 146 (2) ◽  
pp. 177-186 ◽  
Author(s):  
Y. J. PARK ◽  
J. M. KIM ◽  
B. R. LEE ◽  
T. H. KIM ◽  
E. G. LEE

SUMMARYThis study evaluated the annual prevalence of anogenital warts (AGW) caused by human papillomavirus (HPV) and analysed the trend in annual per cent changes (APC) by using national claims data from the Health Insurance Review and Assessment of Korea, 2007–2015. We also estimated the socio-economic burden and co-morbidities of AGW. All analyses were performed based on data for primary A63.0, the specific diagnosis code for AGW. The socio-economic cost of AGW was calculated based on the direct medical cost, direct non-medical cost and indirect cost. The overall AGW prevalence and socio-economic burden has increased during the last 9 years. However, the prevalence of AGW differed significantly by sex. The female prevalence increased until 2012, and decreased thereafter (APC + 3·6%). It would fall after the introduction of routine HPV vaccination, principally for females, in Korea. The male prevalence increased continuously over time (APC + 11·6%), especially in those aged 20–49 years. Referring to the increasing AGW prevalence and its disease burden, active HPV infection control surveillance and prevention in males are worth consideration.


Sign in / Sign up

Export Citation Format

Share Document